MD Sets Payment Limits on Ozempic Amid Rising Prescription Costs
Maryland’s Prescription Drug Affordability Board has taken another step to rein in prescription costs. The Board voted to cap payments for Ozempic in state and local government health plans, a move projected to save public employers millions each year. Maryland’s Prescription Drug Affordability Board (PDAB) determined Ozempic is unaffordable for people living in the state. The Board voted to place upper payment limits on the diabetes and weight-loss drug for state and local government health…